vs
Orthofix Medical Inc.（OFIX）与Sprout Social, Inc.（SPT）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Sprout Social, Inc.的1.8倍（$219.9M vs $120.9M），Sprout Social, Inc.同比增速更快（12.9% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $9.9M），过去两年Sprout Social, Inc.的营收复合增速更高（11.8% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Sprout Social, Inc.是一家提供社交媒体管理平台服务的科技企业，由贾斯汀·霍华德等四位创始人在2010年成立，总部位于美国芝加哥，目前是一家上市企业。其推出的平台能够帮助企业统一管理多渠道社媒账号，开展营销互动与数据分析工作。
OFIX vs SPT — 直观对比
营收规模更大
OFIX
是对方的1.8倍
$120.9M
营收增速更快
SPT
高出10.9%
2.0%
自由现金流更多
OFIX
多$6.9M
$9.9M
两年增速更快
SPT
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $120.9M |
| 净利润 | $-2.2M | — |
| 毛利率 | 71.1% | 77.6% |
| 营业利润率 | 0.2% | -9.0% |
| 净利率 | -1.0% | — |
| 营收同比 | 2.0% | 12.9% |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXSPT
| Q4 25 | $219.9M | $120.9M | ||
| Q3 25 | $205.6M | $115.6M | ||
| Q2 25 | $203.1M | $111.8M | ||
| Q1 25 | $193.6M | $109.3M | ||
| Q4 24 | $215.7M | $107.1M | ||
| Q3 24 | $196.6M | $102.6M | ||
| Q2 24 | $198.6M | $99.4M | ||
| Q1 24 | $188.6M | $96.8M |
净利润OFIXSPT
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-22.8M | $-9.4M | ||
| Q2 25 | $-14.1M | $-12.0M | ||
| Q1 25 | $-53.1M | $-11.2M | ||
| Q4 24 | $-29.1M | — | ||
| Q3 24 | $-27.4M | $-17.1M | ||
| Q2 24 | $-33.4M | $-16.9M | ||
| Q1 24 | $-36.0M | $-13.6M |
毛利率OFIXSPT
| Q4 25 | 71.1% | 77.6% | ||
| Q3 25 | 72.2% | 77.7% | ||
| Q2 25 | 68.7% | 77.7% | ||
| Q1 25 | 62.8% | 77.3% | ||
| Q4 24 | 69.0% | 78.1% | ||
| Q3 24 | 68.7% | 77.4% | ||
| Q2 24 | 67.8% | 77.5% | ||
| Q1 24 | 67.5% | 76.8% |
营业利润率OFIXSPT
| Q4 25 | 0.2% | -9.0% | ||
| Q3 25 | -8.3% | -7.9% | ||
| Q2 25 | -7.9% | -11.0% | ||
| Q1 25 | -25.2% | -10.2% | ||
| Q4 24 | -5.3% | -12.8% | ||
| Q3 24 | -9.6% | -16.4% | ||
| Q2 24 | -12.5% | -16.6% | ||
| Q1 24 | -15.6% | -13.7% |
净利率OFIXSPT
| Q4 25 | -1.0% | — | ||
| Q3 25 | -11.1% | -8.1% | ||
| Q2 25 | -6.9% | -10.7% | ||
| Q1 25 | -27.4% | -10.3% | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | -13.9% | -16.6% | ||
| Q2 24 | -16.8% | -17.0% | ||
| Q1 24 | -19.1% | -14.0% |
每股收益（稀释后）OFIXSPT
| Q4 25 | $-0.05 | $-0.18 | ||
| Q3 25 | $-0.57 | $-0.16 | ||
| Q2 25 | $-0.36 | $-0.21 | ||
| Q1 25 | $-1.35 | $-0.19 | ||
| Q4 24 | $-0.76 | $-0.25 | ||
| Q3 24 | $-0.71 | $-0.30 | ||
| Q2 24 | $-0.88 | $-0.30 | ||
| Q1 24 | $-0.95 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $95.3M |
| 总债务越低越好 | — | $40.0M |
| 股东权益账面价值 | $450.0M | $203.4M |
| 总资产 | $850.6M | $523.1M |
| 负债/权益比越低杠杆越低 | — | 0.20× |
8季度趋势，按日历期对齐
现金及短期投资OFIXSPT
| Q4 25 | $82.0M | $95.3M | ||
| Q3 25 | $62.9M | $90.6M | ||
| Q2 25 | $65.6M | $101.5M | ||
| Q1 25 | $58.0M | $100.9M | ||
| Q4 24 | $83.2M | $86.4M | ||
| Q3 24 | $30.1M | $82.9M | ||
| Q2 24 | $26.4M | $80.9M | ||
| Q1 24 | $27.0M | $69.2M |
总债务OFIXSPT
| Q4 25 | — | $40.0M | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | $25.0M | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | — |
股东权益OFIXSPT
| Q4 25 | $450.0M | $203.4M | ||
| Q3 25 | $442.5M | $194.1M | ||
| Q2 25 | $458.3M | $184.6M | ||
| Q1 25 | $458.3M | $175.3M | ||
| Q4 24 | $503.1M | $166.6M | ||
| Q3 24 | $525.9M | $158.1M | ||
| Q2 24 | $546.0M | $152.1M | ||
| Q1 24 | $570.3M | $147.3M |
总资产OFIXSPT
| Q4 25 | $850.6M | $523.1M | ||
| Q3 25 | $832.6M | $481.4M | ||
| Q2 25 | $837.2M | $422.9M | ||
| Q1 25 | $823.1M | $424.7M | ||
| Q4 24 | $893.3M | $428.3M | ||
| Q3 24 | $867.9M | $388.8M | ||
| Q2 24 | $882.0M | $393.6M | ||
| Q1 24 | $906.0M | $389.9M |
负债/权益比OFIXSPT
| Q4 25 | — | 0.20× | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | 0.15× | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $10.9M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $9.9M |
| 自由现金流率自由现金流/营收 | 7.6% | 8.2% |
| 资本支出强度资本支出/营收 | 4.9% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $39.3M |
8季度趋势，按日历期对齐
经营现金流OFIXSPT
| Q4 25 | $27.7M | $10.9M | ||
| Q3 25 | $12.4M | $9.3M | ||
| Q2 25 | $11.6M | $5.1M | ||
| Q1 25 | $-18.4M | $18.1M | ||
| Q4 24 | $23.7M | $4.1M | ||
| Q3 24 | $11.7M | $9.0M | ||
| Q2 24 | $9.0M | $2.1M | ||
| Q1 24 | $-18.6M | $11.2M |
自由现金流OFIXSPT
| Q4 25 | $16.8M | $9.9M | ||
| Q3 25 | $2.5M | $8.5M | ||
| Q2 25 | $4.5M | $4.2M | ||
| Q1 25 | $-25.1M | $16.7M | ||
| Q4 24 | $15.2M | $3.3M | ||
| Q3 24 | $6.3M | $8.5M | ||
| Q2 24 | $-360.0K | $1.6M | ||
| Q1 24 | $-29.1M | $10.1M |
自由现金流率OFIXSPT
| Q4 25 | 7.6% | 8.2% | ||
| Q3 25 | 1.2% | 7.4% | ||
| Q2 25 | 2.2% | 3.7% | ||
| Q1 25 | -13.0% | 15.3% | ||
| Q4 24 | 7.0% | 3.0% | ||
| Q3 24 | 3.2% | 8.3% | ||
| Q2 24 | -0.2% | 1.6% | ||
| Q1 24 | -15.4% | 10.4% |
资本支出强度OFIXSPT
| Q4 25 | 4.9% | 0.9% | ||
| Q3 25 | 4.8% | 0.7% | ||
| Q2 25 | 3.5% | 0.8% | ||
| Q1 25 | 3.5% | 1.2% | ||
| Q4 24 | 4.0% | 0.8% | ||
| Q3 24 | 2.7% | 0.5% | ||
| Q2 24 | 4.7% | 0.5% | ||
| Q1 24 | 5.6% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
SPT
暂无分部数据
